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1,2 Naturally absent in healthy areas, provisional matrix proteins (ie, FN and fibrinogen) can be detected in atherosclerosis-prone regions concomitant with endothelial activation markers (ICAM [intercellular adhesion molecule]-1 and VCAM [vascular cell adhesion molecule]-1) but before monocyte recruitment, suggesting that subendothelial matrix remodeling is an early event in atherogenesis. 1, 2 Furthermore, preventing FN deposition at these sites significantly reduces plaque burden, 2, 3 associated with reduced endothelial activation and monocyte recruitment. Cell culture studies show that the presence of an FN matrix promotes NF-κB (nuclear factor-κB) signaling and proinflammatory gene expression in response to classic atherogenic mediators, such as oxLDLs (oxidized low-density lipoproteins) and atheroprone hemodynamics. 1, 4 Therefore, subendothelial matrix remodeling critically regulates early endothelial activation during the process of plaque formation.
Despite the well-described role of FN matrix deposition in endothelial activation, the mechanisms regulating FN deposition in the context of atherosclerosis remains largely unknown. The FN that accumulates in the subendothelial matrix during atherogenesis could arise from 2 sources: (1) the leak of circulating plasma FN into the vessel wall or (2) the expression and deposition of cell-derived FN by the endothelium. FN deletion in ECs does not prevent FN staining in models of atheroprone flow in vivo, suggesting that leak of plasma FN is a major source of subendothelial FN. 5 However, the deletion of endothelial FN induces a hemorrhage phenotype, despite the presence of plasma FN, suggesting that the source of FN may critically affect endothelial function. 5 Deposition of endothelial-derived FN is a product of FN expression and activation of the machinery for FN fibrillogenesis, such as the integrin α5β1. Recent studies suggest that endothelial-to-mesenchymal transition (EndMT) is associated with endothelial FN staining at atherosclerosis-prone sites in both mice and humans. 6 Although atheroprone flow patterns enhance FN expression in vitro, 7, 8 vascular regions exposed to atheroprone flow do not show FN deposition in the absence of other atherogenic stimuli, such as hypercholesterolemia. 1, 9 We previously demonstrated that oxLDL stimulates α5β1 integrin activation in ECs in culture, 4 suggesting that alterations in integrin function could contribute to FN deposition. However, the role of oxLDL-mediated integrin activation in endothelial matrix remodeling remains unknown.
Although integrin αvβ3 classically mediates multiple aspects of cardiovascular disease, much less is known about α5β1 in atherosclerosis. 10 Analysis of mRNA and protein isolated from atherosclerotic lesions and injured carotid arteries show increased α5 expression. 11, 12 We have previously shown that inhibiting α5β1 prevents oxLDL-induced NF-κB activation, proinflammatory gene expression, and early atherosclerosis. 4 In addition, α5 −/+ mice and mice expressing an α5/α2 integrin chimera showed significantly reduced inflammation and atherosclerotic plaque size in atheroprone mice. 13, 14 However, the influence of inhibiting α5 integrins on multiple cell types prevents these studies from assessing the role of α5 integrins in endothelial activation directly. For example, it has been demonstrated that inhibiting α5β1 in plaque macrophages alters macrophage migration, phagocytosis, and gene expression, which could certainly contribute to the decrease in atherosclerosis observed with systemic α5 inhibition. [15] [16] [17] Therefore, we sought to assess endothelial α5 integrin signaling in atherogenic endothelial activation using endothelial culture and endothelialspecific knockout model systems.
Methods
The authors declare that all supporting data are available within the article and its online-only Data Supplement.
EC Culture and Transfections
Human aortic ECs (HAECs; Lonza) were purchased at passage 3 (3 different donors) and maintained in MCDB 131 supplemented with 10% fetal bovine serum, 2 mmol/L glutamine, 10 U/mL penicillin (GIBCO), 100 µg/mL streptomycin (GIBCO), 60 µg/mL heparin sodium, and bovine brain extract (25 µg/mL) and were used between passages 6 to 10. Experiments were performed in MCDB 131 containing 0.5% fetal bovine serum. HAECs at 75% confluency were transfected with SMARTpool siRNA oligos targeting FN (50 nmol/L) using Lipofectamine 2000 (Life Technologies) for 2.5 hours on 2 consecutive days, and experiments were performed 1 day later. Mouse aortic ECs (MAECs) were isolated from integrin α5f/fl mice (gift of Richard Hynes, MIT) as previously described. Briefly, aortic rings (3-5 mmol/L) were placed on polymerized Matrigel to induce endothelial sprouts. Sprouting cells were isolated, sorted for the endothelial marker CD105 using magnetic beads, and reversibly transformed using a retroviral temperature-sensitive large T-antigen. The α5 gene was deleted after adenoviral infection with GFP (green fluorescence protein)-Cre or GFP control viruses and sorting for GFP positive cells. The temperature-sensitive large T antigen allows MAEC expansion at 33°C with IFNγ (interferon-γ), whereas moving cells to 37°C in the absence of IFNγ for >3 days abrogates large T-antigen expression. Alternative exon EIIIA (EDA) of FN (EIIIA)/ alternative exon EIIIB (EDB) of FN (EIIIB) MAECs were isolated as previously described. 18, 19 Briefly, aortic ECs were derived from C57 background FN-EIIIAB −/− and FN-EIIIAB +/− littermates. The aorta was isolated from heparinized mice after perfusion via the left ventricle with PBS. Each aortic section was cleaned, filled with collagenase solution and tied at the ends before digestion in 20% fetal bovine serum DMEM. Crude EC isolate was flushed out into dishes coated with collagen I and grown in EC culture media 20% fetal bovine serum, 0.1 mg/mL EC growth supplement from bovine hypothalamus (Sigma) and 0.1 mg/mL heparin with primocin antibiotic in DMEM. After 5 to 7 days, ≈20 000 cells were sorted from each line by markers FITC-acetylated LDL+, Icam2+, and Cd31+ and then immortalized by TetOn-SV40. Cells were subsequently expanded in 1 to 2 μg/mL doxycycline.
Immunoblotting and Immunocytochemistry
Cells were lysed by addition of 2X Laemmli buffer. Lysates were separated by SDS-PAGE gels and were transferred to polyvinylidene difluoride membranes (Bio-Rad, Hercules, CA), and membranes were blocked in 5% nonfat dry milk before addition of primary antibodies. Antibodies used included rabbit anti-FN (Sigma), rabbit anti-P-Smad2/3, rabbit anti-β-Tubulin, rabbit anti-GAPDH, rabbit anti-P-P65 (Ser 536), rabbit anti-P65 (Cell Signaling), rabbit anti-integrin α5, rabbit anti-integrin β1, rabbit anti-integrin β3, mouse anti-EDA-FN, mouse anti-GST (Santa Cruz), and rabbit anti-VCAM-1 (Abcam) as described in the Major Resources Table in the online-only Data Supplement. Densitometry was performed using ImageJ software. Cells were fixed in formaldehyde, permeabilized, and stained. Briefly, cells were fixed for 20 minutes with 4% formaldehyde permeabilized for 10 minutes in 0.1% Triton X-100. Cells were rinsed and blocked with 10% animal serum for at least 1 hour. Cells were then stained with primary antibodies for ≈16 to 18 hours followed by addition of fluorochrome-tagged secondary antibodies (Life Technologies ) mice were treated with 1 mg/kg tamoxifen (Sigma-Aldrich, St Louis, MO) via intraperitoneal injection every other day for 5 total injections to induce Cre expression and gene excision. Previous studies looking at treatment with α5 integrin inhibitors, global α5 transgenics, global α5 knockouts, and FN knockouts all used male mice. Because this study sought to specifically assess the role of endothelial α5 in this regard, we used only males to be consistent with the previous literature. 20 Eight-to 10-week-old mice were fed a high fat, Western diet (TD 88137; Harlan-Teklad, Madison, WI) that contained 21% fat by weight (0.15% cholesterol and 19.5% casein without sodium cholate) for 2 or 8 weeks. Mice were then euthanized by pneumothorax under isoflurane anesthesia, and blood was collected. Total cholesterol, HDL (high-density lipoprotein) cholesterol (Wako Bioproducts, Richmond, VA), and triglycerides (Pointe Scientific, Canton MI) were analyzed with commercially available kits. LDL cholesterol was calculated with the Friedewald equation. Hearts were then perfused with PBS to remove residual blood from the circulation. The lungs were collected for enzymatic digestion and EC isolation by using magnetic beads coupled to ICAM2 antibodies (eBiosource). The left common carotid was collected, and RNA isolation was performed by a TRIzol flush as previously described. Briefly, carotids were cleaned of perivascular adipose tissue and flushed with 150 mL TRIzol from an insulin syringe. The remaining media/adventitia were then placed in 150 mL TRIzol and sonicated to lyse the tissue. Samples were then frozen until analysis by quantitative PCR (polymerase chain reaction). The aortic root, aorta, and carotid sinus were excised, placed in 4% PBS buffered formaldehyde, and analyzed for plaque size and composition or immunostained. Quantification of plaque size was performed in concordance with the American Heart Association Scientific Statement on the design, reporting, and execution of animal atherosclerotic studies. 21 Plaque size in the aorta, from the cusp to the renal arteries, was determined by Oil Red O staining and en face imaging, and quantification of plaque size was determined both for the entire aorta and for the atherosclerosis-prone aortic arch. Plaque size in the aortic root, innominate artery, and carotid sinus was quantified in multiple cross sections within each plaque-prone region as area inside the internal elastic laminae, as assessed by Movat Pentachrome staining.
LDL Oxidation
LDL (Intracel) was oxidized by dialysis in 1X PBS containing 13.8 µmol/L Cu 2 SO 4 for 3 days followed with 50 µmol/L EDTA overnight and then for 4 hours the following day. This consistently displayed a relative electrophoretic mobility between 2 and 3 indicative of highly oxidized LDL. Oxidized LDL was stored under nitrogen gas and tested for endotoxin contamination using a chromogenic endotoxin quantification kit (Thermo Scientific).
Focal Adhesion Isolations
Cells were plated on diluted Matrigel (includes 60% laminin, 30% collagen IV, 8% enactin, and low levels [pg/mL range] of growth factors) coated glass slides in low serum overnight. After treatments, cells underwent hypotonic shock using triethanolamine (2.5 mmol/L at pH 7.0) for 3 minutes. Cell bodies were subsequently removed by pulsed hydrodynamic force (Conair WaterPIK) at ≈0.5 cms from and ≈90° to the surface of the slide scanning the entire length 3 times. Focal adhesions remaining bound to the slide were lysed in 2X Laemmli buffer and separated on SDS-PAGE gels.
Insoluble and Soluble Protein Isolation Using Deoxycholate, by Immunocytochemistry or Western Blotting
Cells were washed once in ice-cold 1X PBS then rinsed twice in Wash buffer 1 (3% Triton X-100 in 1XPBS) for 10 minutes each at mild agitation rates. Cells were then rinsed twice in Wash Buffer 2 (2% sodium deoxycholate, 50 mmol/L Tris-HCl, and pH 8.9) for 10 minutes each at mild agitation rates. Cells were then rinsed twice in 1X PBS for 10 minutes each at mild agitation rates. Cells were then fixed with 4% formaldehyde for 20 minutes followed by blocking with 10% animal serum. Cells were then immunostained as described elsewhere for FN. Alternatively, this protocol can be adapted for Western blotting. Cells were washed in ice-cold 1X PBS then 1 mL of deoxycholate containing buffer (2% sodium deoxycholate, 20 mmol/L Tris-HCl at pH 8.8, 2 mmol/L PMSF, 2 mmol/L iodoacetic acid, and 2 mmol/L N-ethylmaleimide) was added for 10 minutes. Cells were scraped and collected in microcentrifuge tubes followed by passing lysates through a 25g needle 5 times. Lysates were centrifuged at 15 000 RPMs for 15 minutes. Supernatant was collected as the soluble fraction. The remaining pellet was rinsed with deoxycholate buffer and spun again. Buffer was removed and the pellet lysed in 2X Laemmli buffer. Lysate was separated on SDS-PAGE gels.
In Vitro Permeability Assay and Shear Stress
HAECs were transfected with either 150 nmol/L a5 (SMARTPool siRNA; Dharmacon) or Mock control using Lipofectamine 3000 (Invitrogen). After 3 hours, the transfection reagent was removed and the cells were transfected again on the second day. Cells were used for the permeability assay after 12 hours of the second transfection. EC permeability was assessed in a5 siRNA treated cells or controls as previously described. 22 Briefly, cells ( 1×10 6 ) were plated on biotinylated gelatin-coated slides (corning) to confluence and the slides then assembled into a flow chamber to be subjected to disturbed flow as previously described. 23 In brief, oscillatory flow is generated using infusion withdrawal pump (±5 dynes/cm 2 , 1 Hz) with 1 dyne/cm 2 forward flow superimposed by a peristaltic pump. After the cessation of flow, Streptavidin-Alex 647 (1:1000 in PBS, Invitrogen) was immediately added to the cells for 1 minute, then fixed in 4% formaldehyde. F-actin arrangement in static and shear exposed cells was visualized using 488-Alexa phalloidin (Invitrogen) according to manufacturer's recommendation. Images were analyzed using NIS elements software.
FACS Analysis
Cells were removed from the surface using Accutase (Millipore). They were then blocked in 1% denatured albumin for 30 minutes. Cells were spun and incubated 1×10 6 cells/mL with FITC-labeled integrin α5 (Abcam) for 30 minutes, and baseline was established with no antibody and IgG isotype control.
Quantitative PCR
mRNA isolated from tissues and cultured ECs was extracted with TRIzol (Life Technologies, Inc, Carlsbad, CA). Complimentary DNA was synthesized with the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA). Quantitative real-time PCR was performed with a Bio-Rad iCycler with the use of SYBR Green Master mix (Bio-Rad).
Primers were designed with the online Primer3 software and then validated by sequencing the PCR products. Results were expressed as fold change by using the 2ΔΔCT method.
Statistical Analysis
Statistical comparisons between groups were performed using GraphPad Prism software. Data were tested for normality (Kolmogorov-Smirnov test), and data that passed the normality assumption were analyzed using Student t test, 1-way ANOVA with Newman-Keuls post-test, or 2-way ANOVA with Bonferroni post-tests. Data that failed the normality assumption were analyzed by using the nonparametric Mann-Whitney U test and the KruskalWallis test with post hoc analysis. Error bars indicate SE.
Results

Integrin α5 Mediates oxLDL-Induced FN Deposition
Because oxLDL activates endothelial α5β1 integrins, 4 we tested whether oxLDL could also elicit FN deposition in HAECs. Cells plated on basement membrane proteins for ≈28 hours were treated with oxLDL for the final 6 or 24 hours to stimulate α5β1 integrins, and FN deposition into the insoluble matrix fraction was assessed after extraction of the deoxycholate-soluble cell-associated FN. Immunocytochemistry and Western blot analysis for FN reveal that oxLDL treatment causes rapid and robust FN deposition at 6 and 24 hours after treatment ( Figure 1A and 1B) . FN deposition by oxLDL is apparent at concentrations as low as 20 μg/mL and is maximal between 50 and 100 μg/mL (Figure IA in the online-only Data Supplement). This induction of FN deposition was similar to the levels observed in response to the classic profibrotic growth factor TGFβ (transforming growth factor β; Figure IB in the online-only Data Supplement), suggesting that oxLDL is a potent regulator of FN deposition. To assess the specific role of α5β1 in oxLDL-induced FN deposition, we assessed oxLDL-induced matrix remodeling in immortalized MAECs lacking α5. Although α5 wild-type (α5 WT, α5 fl/fl expressing GFP) MAECs show significant FN deposition upon oxLDL treatment, α5 knockout (α5 knockout, α5 fl/fl expressing GFPCre) MAECs show significantly reduced FN deposition associated with diminished FN levels and reduced FN fibril length ( Figure 1C through 1E) . Furthermore, we demonstrate that 2 distinct α5 blocking antibodies (P1D6, SNAKA52) completely prevents oxLDL-induced FN deposition in HAECs ( Figure 1F ).
Previous studies demonstrated that atheroprone hemodynamics contributes to altered FN deposition through enhanced TGFβ signaling, resulting in an EndMT transition that promotes FN deposition. 6 Because oxLDL and TGFβ show similar patterns of FN deposition ( Figure IB 
Endothelial-Specific α5 Deletion Abrogates Atherogenic Inflammation and Early Atherosclerosis
To assess the role of endothelial α5 integrins in early atherogenic inflammation, ApoE knockout mice that express the tamoxifen-inducible, EC-specific Cre transgene (iEC-control) were crossed with mice containing a floxed α5 integrin allele (iEC-α5 knockout) to allow for tamoxifen-dependent α5 deletion in ECs (Figure 2A) . We confirmed the endothelialspecific deletion of α5 by analyzing mRNA isolated from the common carotid intima and media/adventitia ( Figure 3B ) and by Western blotting analysis of lung ECs isolated from iEC-control and iEC-α5 knockout mice ( Figure 2C ). iEC-α5 knockout mice show significant reduction of VCAM-1 expression in the atheroprone aortic arch after 2 weeks high-fat diet feeding, suggesting atherogenic inflammation in reduced in these mice ( Figure 2D ). Paradoxically, iEC-α5 knockout mice did show enhanced endothelial FN staining in atheroprone regions, and to a lesser extent the atheroprotective regions, of the aortic arch ( Figure 2E ). Validity of these staining patterns was verified using controls for nonimmune IgG and secondary antibody alone ( Figure III in the online-only Data Supplement). Previous studies showed that deleting FN from ECs similarly enhanced endothelial FN staining, 5 suggesting that preventing FN deposition at atheroprone sites may enhance vascular permeability. Consistent with this model, deposition of fibrinogen, a plasma protein not expressed in ECs, was similarly enhanced in iEC-α5 knockout mice ( Figure  IVA in the online-only Data Supplement), and α5 knockout MAECs showed enhanced permeability in cell culture models ( Figure IVB in the online-only Data Supplement). Although αvβ3 has been proposed to promote FN deposition in the absence of α5β1, deletion of endothelial αv alone did not affect endothelial FN staining, and deletion of both α5 and αv in the endothelial layer showed increased FN deposition similar to the α5 endothelial knockout alone ( Figure V in the onlineonly Data Supplement). Therefore, the enhanced FN staining in the endothelial α5 knockout is not likely because of compensation by another FN-binding integrin.
After 8 weeks high-fat diet, iEC-α5 knockout mice show no differences in plasma lipid levels ( Figure VI in the onlineonly Data Supplement) but show significantly reduced atherosclerotic plaque area as assessed by oil red O staining of the aorta ( Figure 3A) and by cross-sectional analysis of the aortic root ( Figure 3B ), innominate artery ( Figure 3C) , and carotid sinus ( Figure 3D ). 21 Consistent with a role in endothelial activation, loss of endothelial α5 expression reduces macrophage accumulation in both the aortic root and innominate arteries ( Figure 3E and 3F ). Previous studies show that loss of plasma FN reduces smooth muscle accumulation and fibrous cap size. 2 Because loss of α5 reduces FN assembly, we examined total smooth muscle cell area and collagen content in the more advanced plaques of the aortic root. Our results show that endothelial α5 deletion does not negatively impact smooth muscle content ( Figure 3G ) or collagen content in these plaques ( Figure 3H ).
Cell-Derived, Not Plasma-Derived, FN Mediates VCAM-1 Expression Induced by oxLDL
We and others have shown that EC interactions with FN tune the response to atherogenic mediators to increase proinflammatory gene expression. 24 Although α5 may be important for some of these responses, several groups have shown an important role for other FN-binding integrins, such as αvβ3, in endothelial activation. 25, 26 Therefore, the loss of endothelial VCAM-1 staining in iEC-α5 knockout mice, despite the presence of FN in the EC layer suggests that cell-derived and plasma-derived FN have different roles in endothelial activation. To assess this, we depleted FN from HAECs (siRNA) and from the cell culture media (FN-depleted serum; Figure  VII in the online-only Data Supplement) and assessed oxLDL-induced VCAM-1 expression. Although FN depletion blunted both baseline and oxLDL-induced VCAM-1 expression ( Figure 4A ), addition of plasma FN was unable to rescue this phenotype. In contrast, addition of cell-derived FN isolated from human foreskin fibroblasts successfully restored oxLDL-induced VCAM-1 expression ( Figure 4B ). Because the primary difference between plasma-derived and cell-derived FN is the inclusion of the additional FN type III repeats EIIIA and EIIIB in cell-derived FN, we assessed the role of EIIIA and EIIIB in oxLDL-induced inflammation using MAECs isolated from EIIIA/EIIIB knockout mice. Consistent with a critical role for cell-derived FN in this response, oxLDL-induced VCAM-1 expression in EIIIA/ EIIIB wildtype (EIIIA/B WT) but not EIIIA/EIIIB knockout (EIIIA/B knockout) MAECs ( Figure 4C ). Consistent with reduced VCAM-1 expression, oxLDL-induced NF-κB activation was significantly suppressed in HAECs depleted of cellular FN (FN siRNA) and in EIIIA/EIIIB knockout MAECs ( Figure 4D and 4E) . Taken together, these results suggest that , ApoE −/− ) mice were treated with tamoxifen (1 mg in peanut oil for 5 consecutive days) and fed a Western diet for 2 wk. B, α5 expression in the carotid intima and media was assessed by quantitative real-time polymerase chain reaction after the TRIzol flush method. n=6. C, Lung endothelial cells were isolated from post-tamoxifen-treated mice, and α5 expression was assessed by immunoblotting. n=4. D and E, Two wk after Western diet feeding, mice were euthanized, and transverse sections of the aortic arch were assessed by immunohistochemistry for (D) VCAM-1 (vascular cell adhesion molecule 1; red) and (E) FN (fibronectin; red). Endothelial cells (EC) were identified by staining for VWF (green), and DAPI (blue) was used to show nuclear staining. Representative images are shown (n=6). Images were taken at ×20. Analysis of EC positivity for VCAM-1 or FN staining in the upper curvature and lesser curvature of the aortic arch was performed using NIS elements software. n=6 mice per group. Values are means±SE. *P<0.05 and ***P<0.001 compared with iEC-Ctrl. VWF indicates von Willebrand factor.
oxLDL-induced NF-κB activation and VCAM-1 expression are mediated by EC-derived FN.
Ablation of Cell-Derived FN Limits oxLDL-Induced FN Fibrillogenesis
The requirement for cell-derived FN could be because of specific EIIIA/EIIIB receptors, alterations in the cell's ability to deposit plasma FN, or changes in the presentation of the integrin-binding sites by EIIIA/EIIIB inclusion. Because cell-derived FN does not stimulate VCAM-1 expression in the absence of oxLDL (Figure 4B ), the direct activation of EIIIA/EIIIB receptors is unlikely. To evaluate the role of cell-derived FN in oxLDL-induced FN assembly, HAECs plated on basement membrane proteins were stimulated with oxLDL and deposition of plasma FN (488-labeled plasma FN added to cell culture medium) and cell-derived FN (positive for the alternatively spliced EIIIA site) was assessed by confocal microscopy. We observed that oxLDL treatment enhances both plasma-derived and cell-derived FN staining in the subendothelial matrix ( Figure 5A ). To assess whether cell-derived FN regulates plasma FN assembly, we measured deposition of plasma-derived FN in HAECs treated with FN siRNA to specifically deplete cell-derived FN. Although plasma FN staining after oxLDL treatment did not change with endothelial FN knockdown ( Figure 5B and 5C), the lack of cell-derived FN significantly limited the size of the FN fibrils that formed ( Figure 5D ). Moreover, EIIIA/EIIIB knockout MAECs, which still express FN lacking these alternative domains, showed a similar abrogation of FN assembly in response to oxLDL (Figure 5E ), suggesting that it is the inclusion of the EIIIA/EIIIB domains rather than retained ability to express FN that regulates endothelial FN deposition.
Previous studies indicate that loss of cell-derived FN results in decreased staining of α5 integrins in focal adhesions, potentially accounting for decreased FN assembly after oxLDL treatment and decreased proinflammatory gene expression. 27 Therefore, we examined if FN deletion in HAECs altered α5β1 recruitment to focal adhesions. HAECs were treated with oxLDL for 6 hours, and the focal adhesion fraction was isolated. Our results demonstrate that FN knockdown decreases α5β1 levels within focal adhesions ( Figure 6A and 6B), whereas α5 surface levels remain unchanged ( Figure  VIII in the online-only Data Supplement). Similarly, oxLDL enhanced α5β1 adhesions in HAECs as assessed by immunocytochemistry for α5 and active β1 integrins (12G10 antibody, gift of Martin Humphries, University of Manchester, England), and depletion of cell-derived FN significantly reduced α5 and β1 integrin staining at focal/fibrillar adhesions ( Figure 6C ). Using oxLDL-treated EIIIA/EIIIB double knockout MAECs, we demonstrated that preventing EIIIA/EIIIB inclusion in cell-derived FN blunts oxLDL-induced α5 focal adhesion formation as assessed by Western blotting (Figure 7A and 7B) and immunostaining ( Figure 7C ). Consistent with this, rescuing FN-depleted HAECs with cell-derived FN, but not plasma FN, supports oxLDL-induced α5 focal adhesion formation ( Figure 7D ). Together, these data suggest that cell-derived FN regulates α5β1 adhesion formation to promote FN assembly and inflammation in response to oxLDL.
Discussion
Although FN deposition contributes to endothelial activation in early atherogenesis, the mechanisms regulating FN deposition remain poorly characterized. Although previous studies have shown that disturbed flow patterns regulate endothelial FN expression, FN is absent in regions of disturbed flow in the absence of other stimuli, such as hypercholesterolemia or hyperglycemia. 1, 2, 9 We previously demonstrated that oxLDL drives activation of the FN-binding integrin α5β1, suggesting that oxLDL may promote early FN deposition in atherosclerosis. 4 Here, we show that oxLDL drives a robust increase in endothelial FN deposition and define a critical role for α5β1 integrins in this response. OxLDLinduced α5β1 signaling on FN has also been shown to increase endothelial NF-κB activation, VCAM-1 expression, and monocyte adhesion. Our data demonstrate that endothelial-specific deletion of α5 integrins blunts VCAM-1 expression during early atherogenesis and limits atherosclerotic plaque formation, characterized by reduced macrophage accumulation in plaque. However, this decrease in inflammation did not correlate with reduced FN content in the vessels, presumably because of enhanced leak of plasma FN into the vessel wall consistent with previous reports.
5, 27 We further show that only cell-derived FN mediates oxLDL-induced proinflammatory responses, whereas plasma-derived FN lacks these proinflammatory properties. We further narrowed the proinflammatory properties of cell-derived FN to the presence of the EIIIA/EIIIB alternatively spliced domains and showed that the presence of EIIIA/EIIIB domains was required for efficient FN fibrillogenesis in response to oxLDL. Loss of EIIIA/EIIIB-containing FN prevented α5β1 recruitment to focal and fibrillary adhesions, consistent with a role for these domains in the presentation of FN integrinbinding sites. [28] [29] [30] [31] Although FN deposition is seen only in regions of turbulent blood flow, these sites are largely devoid of FN in the absence of atherogenic risk factors, such as hypercholesterolemia or hyperglycemia. 1, 9 Furthermore, laminar flow significantly inhibits FN deposition, whereas FN deposition is only mildly enhanced by disturbed flow patterns compared with static culture conditions. 8, 9 Although disturbed flow patterns have been shown to promote FN expression through NF-κB-, β-catenin-, and TGFβ-induced Smad2 signaling, [6] [7] [8] treatment with oxLDL failed to induce FN expression at either the mRNA or protein level ( Figure IIC in the online-only Data Supplement; Figure 4) . Similarly, oxLDL did not induce the EndMT transition previously associated with FN deposition at atherosclerosis-prone sites. 6 Rather, treatment with oxLDL drives α5β1 activation, fibrillary adhesion formation, and α5β1-dependent FN deposition in the absence of altered FN expression. ECs express multiple  FN-binding integrins (α5β1, αvβ3, and α5β1) , and embryonic endothelial-specific deletion of α5 integrins does not compromise developmental angiogenesis. However, knockout of both α5 and αv integrins results in extensive defects in remodeling of the vessels and heart, suggesting that the FN-binding integrins are functionally redundant in development. 32 Although endothelial-specific deletion of α5 integrins paradoxically enhances endothelial FN staining ( Figure 2E ), this effect may be because of enhanced leak of plasma FN into the vessel at these sites because the plasma protein fibrinogen shows a similar staining pattern and endothelial knockdown of α5 enhances permeability in culture ( Figure IV in the online-only Data Supplement). Interestingly, our data show that only endothelial deletion of α5 integrins enhances FN staining, whereas αv knockout did not show the same pattern ( Figure V in the online-only Data Supplement), suggesting that the enhanced FN staining after endothelial α5 deletion is not because of compensation by other FN-binding integrins.
FN has been ascribed multiple roles in the pathogenesis of atherosclerotic plaque formation. In the subendothelial matrix, FN regulates proinflammatory endothelial activation in response to shear stress and oxLDL, and inhibiting FN deposition or endothelial FN-binding integrins (α5β1 and αvβ3) prevent(s) atherogenic endothelial activation. [2] [3] [4] 14, 25 Our data suggest that α5β1 may play multiple roles in FN-associated inflammation, as it is implicated in both FN-dependent proinflammatory signaling 4, 13, 14 and oxLDL-dependent FN deposition. Although inhibiting FN-binding integrins reduce atherogenic inflammation, mice deficient in plasma FN and mice globally deficient in EIIIA inclusion both show reduced smooth muscle incorporation into the atherosclerotic plaque, 2, 33 suggesting an important role for FN in plaque stability. However, only αvβ3 inhibitors, and not α5β1 inhibitors, showed a similar reduction in plaque smooth muscle content, 4, 25 and neither αv nor α5 deletion in ECs altered smooth muscle content. Taken together, these data suggest that inhibiting α5β1 integrins may reduce plaque-associated inflammation without negatively affecting plaque stability.
FN deposition contributes to immune cell recruitment in various ways. Previous studies, and our data here, demonstrate that FN deposition into the subendothelial matrix increases EC activation by multiple atherogenic stimuli. [1] [2] [3] 34 Modified LDL was previously reported to induce apical presentation of FN containing the alternatively spliced connecting segment-1 domain. 35 Connecting segment-1 provides direct interaction sites for α4β1-bearing leukocytes, conceivably enhancing leukocyte interactions with the blood vessel wall and contributing to atherosclerotic plaque development. However, it was later shown ex vivo that only a minority of monocyte interactions with the endothelium occur through connecting segment-1 FN. 36 Moreover, our results examining Z-stack projections show both plasma-derived and cell-derived FN only at intercellular, intracellular, or subendothelial spaces. Depletion of endothelial FN (FN knockdown and depletion of serum FN) reduced both baseline and oxLDL-induced VCAM-1 expression (Figure 4) . However, only rescue with cell-derived FN rescued oxLDL-induced VCAM-1 expression. Furthermore, oxLDL failed to induce VCAM-1 in ECs lacking the EIIIA and EIIIB alternatively spliced domains found in cell-derived FN but absent from plasma FN, suggesting a key role for the EIIIA/EIIIB domain in the oxLDL-induced inflammatory response. 37, 38 Although EIIIA and EIIIB-containing FN significantly contributes to plaque formation, [39] [40] [41] the link between these 2 remain undefined. EIIIA contains additional binding sites for integrins α4β1 and α9β1, 42 however, these integrins are not expressed in arterial ECs. 25 EIIIA has also been shown to bind to TLR4 (Toll-like receptor 4), and deletion of TLR4 reduces atherosclerosis in mice with constitutive inclusion of EIIIA. 39 However, ApoE knockout mice are prone to endotoxemia, 43, 44 and these studies ignore the potential antiinflammatory effect of TLR4 deletion on exacerbated atherosclerosis by other ligands. Furthermore, TLR4 activation is sufficient to induce VCAM-1 expression, and treatment with cell-derived FN was not sufficient to induce VCAM-1 expression in the absence of oxLDL (Figure 4) . Rather, our data support the hypothesis that EIIIA/EIIIB inclusion affects the interaction between FN and its integrin receptors [28] [29] [30] [31] because endothelial FN knockdown and ECs lacking the EIIIA/EIIIB domains both show reduced α5β1 incorporation into focal and fibrillar adhesions. This enhancement in α5β1 signaling likely mediates proinflammatory responses to EIIIA/EIIIB in ECs, as oxLDL-induced inflammation requires α5β1-dependent NF-κB activation through a focal adhesion kinase-dependent pathway.
